Hemispherx Biopharma
Philadelphia, US
Biotech
Founders & leadership
TK
Thomas K EquelsExecutive Officer, Director
AK
Adam K PascaleExecutive Officer
SW
Stewart W AppelrouthDirector
WK
William K MitchellDirector
DK
David K StrayerExecutive Officer
PW
Peter W RodinoDirector
WK
Wayne K SpringateExecutive Officer
Reported raises · per SEC filings
Form D private placements$3.3MraisedFeb 2024 · 1 investors · Biotechnology
Rule 506(b)$25.7KraisedApr 2018 · 3 investors · Pharmaceuticals
Rule 506(b)$18.2KraisedFeb 2017 · 4 investors · Pharmaceuticals
Rule 506(b)$33.3KraisedSep 2016 · 3 investors · Pharmaceuticals
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.